Volume 8 Supplement 1

14th Scientific Symposium of the Austrian Pharmacological Society (APHAR)

Open Access

US28 in melanoma growth

  • Elisabeth Moser1,
  • Joshi Shripad2,
  • Helmut Schaider2 and
  • Maria Waldhoer1
BMC Pharmacology20088(Suppl 1):A2

https://doi.org/10.1186/1471-2210-8-S1-A2

Published: 5 November 2008

The human cytomegalovirus (hCMV) encodes the G protein-coupled receptor (vGPCR) US28. This receptor signals constitutively and interacts with a broad range of chemokines, which are crucial to the pathophysiological significance and immunoregulatory aspects of this receptor. Chemokines and their receptors have been shown to be key determinants of tumor growth and formation of metastases. US28 exerts anti-tumorigenic effects in two melanoma cell lines. Here we show that in contrast to all other previously studied cell lines, US28 is expressed on the cell surface in the melanoma cell lines Sbcl2 and 451Lu. We found that GASP – the G protein-coupled receptor-associated sorting protein – which sorts US28 and many other GPCRs to the lysosomes is absent in melanoma cells. The absence of GASP might affect the tumor-suppressing properties of US28. Melanoma cells produce several chemokines, one of them is the monocyte chemoattractant protein-1 (MCP-1). We found that the MCP-1 level in the supernatants of 451Lu cells increased when US28 wt was expressed. US28Δ317, a truncated mutant of US28 which is known to have enhanced signalling capacity compared to US28 wt, increased the MCP-1 concentration up to 20-fold. We speculate that the constitutive signalling of the receptor regulates the MCP-1 production of melanoma cells.

Authors’ Affiliations

(1)
Institute of Experimental and Clinical Pharmacology, Medical University of Graz
(2)
Department of Dermatology, Medical University of Graz

Copyright

© Moser et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd.

Advertisement